Novel Ciprofloxacin-Modifying Enzyme (CrpP) Encoded by the Pseudomonas aeruginosa pUM505 Plasmid.

scientific article published on 26 March 2018

Novel Ciprofloxacin-Modifying Enzyme (CrpP) Encoded by the Pseudomonas aeruginosa pUM505 Plasmid. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/AAC.02629-17
P932PMC publication ID5971611
P698PubMed publication ID29581123

P50authorJesús Campos-GarcíaQ54457387
Victor Meza-CarmenQ80135229
Martha I Ramírez-DíazQ81185858
P2093author name stringJesús Silva-Sánchez
J Félix Gutiérrez-Corona
Víctor M Chávez-Jacobo
Juan Pablo García-Merinos
Karen C Hernández-Ramírez
Pamela Romo-Rodríguez
Rocío Viridiana Pérez-Gallardo
P2860cites workPlasmid-mediated quinolone resistance: a multifaceted threatQ24645356
The Current Case of Quinolones: Synthetic Approaches and Antibacterial ActivityQ26752640
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectorsQ26778475
A new mathematical model for relative quantification in real-time RT-PCRQ27860781
The quinolones: decades of development and useQ28191758
Aminoglycoside phosphotransferases: proteins, structure, and mechanismQ28292695
Chromosomal genetics of PseudomonasQ29615288
Construction of improved Escherichia-Pseudomonas shuttle vectors derived from pUC18/19 and sequence of the region required for their replication in Pseudomonas aeruginosaQ29615291
Cloning, nucleotide sequence, and expression of the chromate resistance determinant of Pseudomonas aeruginosa plasmid pUM505Q33884667
Genomic analysis and temperature-dependent transcriptome profiles of the rhizosphere originating strain Pseudomonas aeruginosa M18.Q34007844
Aminoglycoside modifying enzymesQ34354185
Aminoglycoside antibiotic resistance by enzymatic deactivationQ35014471
Directed evolution of aminoglycoside phosphotransferase (3') type IIIa variants that inactivate amikacin but impose significant fitness costsQ35034759
Genes from pUM505 plasmid contribute to Pseudomonas aeruginosa virulenceQ35887599
Mechanisms of drug resistance: quinolone resistanceQ36225422
Analysis of the protective capacity of three Streptococcus suis proteins induced under divalent-cation-limited conditionsQ36539610
Mechanism of quinolone action and resistanceQ37701591
Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary successQ38212925
A plasmid-encoded UmuD homologue regulates expression of Pseudomonas aeruginosa SOS genes.Q41006803
Nucleotide sequence of Pseudomonas aeruginosa conjugative plasmid pUM505 containing virulence and heavy-metal resistance genes.Q42594565
Transfer of quinolone resistance gene qnrA1 to Escherichia coli through a 50 kb conjugative plasmid resulting from the splitting of a 300 kb plasmidQ42644738
Amino acid residues involved in cold adaptation of isocitrate lyase from a psychrophilic bacterium, Colwellia marisQ45094873
Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosaQ46397999
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferaseQ46862305
Plasmid pUM505 encodes a Toxin-Antitoxin system conferring plasmid stability and increased Pseudomonas aeruginosa virulence.Q47712644
Resistance to metals by Pseudomonas aeruginosa clinical isolates.Q52458761
Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria.Q54127746
Mechanism of action of and resistance to quinolonesQ58057075
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectPseudomonas aeruginosaQ31856
P577publication date2018-05-25
P1433published inAntimicrobial Agents and ChemotherapyQ578004
P1476titleCrpP Is a Novel Ciprofloxacin-Modifying Enzyme Encoded by the Pseudomonas aeruginosa pUM505 Plasmid
P478volume62

Reverse relations

cites work (P2860)
Q92051378Characterization of Mechanisms Lowering Susceptibility to Flumequine among Bacteria Isolated from Chilean Salmonid Farms
Q89668220Combining Standard Molecular Typing and Whole Genome Sequencing to Investigate Pseudomonas aeruginosa Epidemiology in Intensive Care Units
Q92214984High frequency of the exoU+/exoS+ genotype associated with multidrug-resistant "high-risk clones" of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals
Q89766030Hypermutator Pseudomonas aeruginosa exploits multiple genetic pathways to develop multidrug resistance during long-term infections in the airways of cystic fibrosis patients
Q90636536Palmatine Is a Plasmid-Mediated Quinolone Resistance (PMQR) Inhibitor That Restores the Activity of Ciprofloxacin Against QnrS and AAC(6')-Ib-cr-Producing Escherichia coli

Search more.